New Discovery May Significantly Broaden the Applicability of T-Cell Immunotherapy
[vc_row][vc_column][vc_column_text] Researchers at the University of Cardiff discovered that MR1-restricted T-cells can be used to broaden both the types of cancer and patients that can be treated using cellular therapy. During the past decade, cancer immunotherapy has emerged, along with surgery, radiation, and chemotherapy, as a fourth,...